PVLA
Palvella Therapeutics
PVLA
PVLA
115 hedge funds and large institutions have $179M invested in Palvella Therapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
23% less capital invested
Capital invested by funds: $232M → $179M (-$53.7M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $486K
Holders
115
Holding in Top 10
2
Calls
$1K
Puts
$486K
Top Buyers
| 1 | +$8.89M | |
| 2 | +$4.48M | |
| 3 | +$4.04M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.37M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.19M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$4.44M | |
| 3 | -$3.77M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$3.56M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$2.96M |